RCKT
Price
$2.96
Change
+$0.19 (+6.86%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
318.9M
69 days until earnings call
SVRA
Price
$2.40
Change
-$0.00 (-0.00%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
414.81M
65 days until earnings call
Interact to see
Advertisement

RCKT vs SVRA

Header iconRCKT vs SVRA Comparison
Open Charts RCKT vs SVRABanner chart's image
Rocket Pharmaceuticals
Price$2.96
Change+$0.19 (+6.86%)
Volume$83.91K
Capitalization318.9M
Savara
Price$2.40
Change-$0.00 (-0.00%)
Volume$22.45K
Capitalization414.81M
RCKT vs SVRA Comparison Chart
Loading...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RCKT vs. SVRA commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RCKT is a Hold and SVRA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (RCKT: $2.77 vs. SVRA: $2.40)
Brand notoriety: RCKT and SVRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RCKT: 174% vs. SVRA: 161%
Market capitalization -- RCKT: $298.43M vs. SVRA: $414.81M
RCKT [@Biotechnology] is valued at $298.43M. SVRA’s [@Biotechnology] market capitalization is $414.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $307.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RCKT’s FA Score shows that 1 FA rating(s) are green whileSVRA’s FA Score has 0 green FA rating(s).

  • RCKT’s FA Score: 1 green, 4 red.
  • SVRA’s FA Score: 0 green, 5 red.
According to our system of comparison, RCKT is a better buy in the long-term than SVRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RCKT’s TA Score shows that 4 TA indicator(s) are bullish while SVRA’s TA Score has 5 bullish TA indicator(s).

  • RCKT’s TA Score: 4 bullish, 5 bearish.
  • SVRA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SVRA is a better buy in the short-term than RCKT.

Price Growth

RCKT (@Biotechnology) experienced а -55.82% price change this week, while SVRA (@Biotechnology) price change was -15.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.48%. For the same industry, the average monthly price growth was +5.47%, and the average quarterly price growth was +1.42%.

Reported Earning Dates

RCKT is expected to report earnings on Aug 11, 2025.

SVRA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+8.48% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SVRA($415M) has a higher market cap than RCKT($319M). SVRA YTD gains are higher at: -21.824 vs. RCKT (-77.963). SVRA has higher annual earnings (EBITDA): -88.58M vs. RCKT (-246.03M). RCKT has more cash in the bank: 318M vs. SVRA (219M). RCKT (25.4M) and SVRA (26.7M) have identical debt. RCKT (0) and SVRA (0) have equivalent revenues.
RCKTSVRARCKT / SVRA
Capitalization319M415M77%
EBITDA-246.03M-88.58M278%
Gain YTD-77.963-21.824357%
P/E RatioN/AN/A-
Revenue00-
Total Cash318M219M145%
Total Debt25.4M26.7M95%
FUNDAMENTALS RATINGS
RCKT vs SVRA: Fundamental Ratings
RCKT
SVRA
OUTLOOK RATING
1..100
536
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
70
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9889
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RCKT's Valuation (15) in the Biotechnology industry is somewhat better than the same rating for SVRA (70). This means that RCKT’s stock grew somewhat faster than SVRA’s over the last 12 months.

RCKT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as SVRA (100). This means that RCKT’s stock grew similarly to SVRA’s over the last 12 months.

RCKT's SMR Rating (100) in the Biotechnology industry is in the same range as SVRA (100). This means that RCKT’s stock grew similarly to SVRA’s over the last 12 months.

SVRA's Price Growth Rating (89) in the Biotechnology industry is in the same range as RCKT (98). This means that SVRA’s stock grew similarly to RCKT’s over the last 12 months.

SVRA's P/E Growth Rating (100) in the Biotechnology industry is in the same range as RCKT (100). This means that SVRA’s stock grew similarly to RCKT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RCKTSVRA
RSI
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 8 days ago
84%
Bearish Trend 8 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
64%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BGAFX40.50N/A
N/A
Baron Global Advantage Retail
PFSQX24.82N/A
N/A
PGIM Jennison Financial Services R6
MDSCX12.45N/A
N/A
BlackRock Sustainable Advantage Gl EqIns
PNORX110.51N/A
N/A
Putnam Sustainable Leaders R
TCPWX12.60N/A
N/A
Transamerica Capital Growth R6

RCKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCKT has been loosely correlated with SVRA. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if RCKT jumps, then SVRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCKT
1D Price
Change %
RCKT100%
+10.36%
SVRA - RCKT
61%
Loosely correlated
+5.26%
IDYA - RCKT
58%
Loosely correlated
+6.69%
PRTA - RCKT
54%
Loosely correlated
+1.53%
ERAS - RCKT
54%
Loosely correlated
+1.79%
STOK - RCKT
52%
Loosely correlated
+3.88%
More

SVRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SVRA has been loosely correlated with RCKT. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if SVRA jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SVRA
1D Price
Change %
SVRA100%
+5.26%
RCKT - SVRA
61%
Loosely correlated
+10.36%
PRTA - SVRA
46%
Loosely correlated
+1.53%
KYMR - SVRA
45%
Loosely correlated
+45.51%
LRMR - SVRA
43%
Loosely correlated
-2.00%
CCCC - SVRA
42%
Loosely correlated
+6.40%
More